NASDAQ: DNADSocial Capital Suvretta Holdings Corp Iv Stock
$10.22-0.01 (-0.1%)
Updated Mar 29, 2023
DNAD Price
$10.22
Fair Value Price
N/A
Market Cap
$325.92M
52 Week Low
$9.65
52 Week High
$10.92
P/E
N/A
P/B
-44.87x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
$547.06k
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-1.08
Operating Cash Flow
N/A
Beta
0.01
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
DNAD Overview
Social Capital Suvretta Holdings Corp. IV is a "blank check" company formed to effect mergers, share exchanges, asset acquisitions, share purchases, reorganizations, or similar business combinations. It targets businesses in the biotechnology industry and the immunology subsector. Social Capital Suvretta Holdings Corp. IV was incorporated in 2021 and is based in Henderson, NV.
Zen Score
–
Industry Average (7)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how DNAD scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
DNAD's short-term assets ($563.71k) exceed its short-term liabilities ($127.67k)
Short-term Liabilities Financials
DNAD's long-term liabilities ($7.70M) exceed its short-term assets ($563.71k)
Long-term Liabilities Financials
DNAD's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
There are 30 more DNAD due diligence checks available for Premium users.
Be the first to know about important DNAD news, forecast changes, insider trades & much more!
DNAD News
Valuation
DNAD fair value
Fair Value of DNAD stock based on Discounted Cash Flow (DCF)
Price
$10.22
Fair Value
$10.11
Overvalued by
1.13%
DNAD price to earnings (PE)
For valuing profitable companies with steady earnings
Company
0x
Industry
22.38x
Market
21.81x
DNAD price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-44.87x
Industry
-37.22x
DNAD's financial health
Profit margin
Revenue
$0.0
Net Income
$922.6k
Profit Margin
0%
Assets to liabilities
Assets
$252.1M
Liabilities
$7.8M
Debt to equity
-1.08
DNAD's short-term assets ($563.71k) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
DNAD's long-term liabilities ($7.70M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
DNAD's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
DNAD's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$128.7k
Investing
$0.0
Financing
$0.0
DNAD vs Shell Company Stocks
Social Capital Suvretta Holdings Iv Stock FAQ
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.